Biomarkers of ovulation, endometrial receptivity, fertilisation, implantation and early pregnancy progression

Paediatric and Perinatal Epidemiology

Volumn 20, Issue SUPPL. 1, 2006, Pages 13-25

  Campbell, Kenneth L ^a   Rockett, John C ^b  

^a UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^b ROSETTA INPHARMATICS   (United States)

Author keywords

Biomarkers; Fertilisation; Implantation; Ovulation; Pregnancy

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; EARLY PREGNANCY FACTOR;

CONFERENCE PAPER; DNA DETERMINATION; ENDOMETRIUM; ENVIRONMENT; FEMALE GENITAL SYSTEM; FERTILIZATION; GENETIC ANALYSIS; HUMAN; IMPLANTATION; MEDICAL LITERATURE; OUTCOME ASSESSMENT; OVULATION; PREGNANCY;

BIOLOGICAL MARKERS; EMBRYO IMPLANTATION; ENDOMETRIUM; EPIDEMIOLOGIC STUDIES; FEMALE; FERTILIZATION; HUMANS; OVULATION; PREGNANCY;

EID: 33750251816     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/j.1365-3016.2006.00766.x     Document Type: Conference Paper

References (99)

1. Chapin RE, Robbins WA, Schieve LA, Sweeney AM, Tabacova SA, Tomashek KM. Off to a good start: the influence of pre- and periconceptional exposures, parental fertility, and nutrition on children's health. Environmental Health Perspectives 2004; 112:69-78.
2. Eaton W. The logic for a conception-to-death cohort study. Annals of Epidemiology 2002; 12:445-451.
3. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. New England Journal of Medicine 1988; 19:189-194.
4. Santow G, Bracher M. Do gravity and age affect pregnancy outcome? Social Biology 1989; 36:9-22.
5. Wood JW. Dynamics of Human Reproduction: Biology, Biometry, Demography. Hawthorne, NY: Aldine De Gruyter, 1994.
6. Biggers JD. Fecundability. Annals of the New York Academy of Sciences 1988; 541:706-714.
7. Campbell KL. Monitoring ovarian function and predicting ovulation: summary of a meeting. Research Frontiers in Fertility Regulation 1985; 3:1-16.
8. Papanicolaou GN. The sexual cycle in the human female as revealed by vaginal smears. American Journal of Anatomy 1933; 52(Suppl.):519-637.
9. Taylor ES, McCallin AF. A correlation of the cytology of the urinary sediment with endometrial histology. American Journal of Obstetrics and Gynecology 1952; 63:1009-1018.
10. Strasinger S. Urinalysis and Body Fluids: A Self-Instructional Text, 2nd edn. Philadelphia, PA: FA Davis, Co, 1989.
11. Landon J, Mahmod S. Distribution of drugs between blood and saliva. In: Ninth Tenovus Workshop: Immunoassays of Steroids in Saliva. Editors: Read GF, Riad-Fahmy D, Walker RF, Griffiths K. Cardiff, Wales: Alpha Omega Publishing Ltd, 1984; pp. 47-55.
12. World Health Organisation. WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. New York, NY: Cambridge University Press, 1987.
13. Long J, Evans H. The estrous cycle of the rat and its associated phenomena. Memories of the University of California 1922; 6:1-148.
14. Sato T, Fukazawa Y, Kojima H, Enari M, Iguchi T, Ohta Y. Apoptotic cell death during the estrous cycle in the rat uterus and vagina. Anatomical Record 1997; 248:76-83.
15. Moore KL. The urogenital system. Chapter 13. In: The Developing Human: Clinically Oriented Embryology, 4th edn. Philadelphia, PA: W.B. Saunders Co, 1988; pp. 246-285.
16. Solomon C, Panagotopoulos P, Oppenheim A. The use of urinary sediment as an aid in endocrinological disorders in the female. American Journal of Obstetrics and Gynecology 1958; 76:56-60.
17. Perriton CL, Powles N, Chiang C, Maconochie MK, Cohn MJ. Sonic hedgehog signaling from the urethral epithelium controls external genital development. Developmental Biology 2002; 247:26-46.
18. Bravo AA. [Cytology of the urinary sediment in gynecology & obstetrics.] Revista de Obstetricia y Ginecologia de Venezuela 1957; 17:524-557 (Spanish).
19. Jung H, Niesert W. [Quantitative urinary sediment in normal pregnancy and its diagnostic significance in late pregnancy toxemias.] Geburtshilfe und Frauenheilkunde 1963; 23:379-389 (German).
20. Korepanova EF. [Cytology of the secretion of the female urethra.] Akusherstvo i Ginekologiia 1958; 34:100-101 (Russian).
21. Midgley AR Jr, Jaffe RB. Human luteinizing hormone in serum during the menstrual cycle: determination by radioimmunoassay. Journal of Clinical Endocrinology and Metabolism 1966; 26:1375-1381.
22. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. International Journal of Fertility 1967; 12:77-126.
23. Marinho AO, Sallam HN, Goessens L, Collins WP, Campbell S. Ovulation side and occurrence of mittelschmerz in spontaneous and induced ovarian cycles. British Medical Journal (Clinical Research Ed) 1982; 284:632.
24. World Health Organisation Task Force on Methods for the Determination of the Fertile Period. Temporal relationships between indices of the fertile period. Fertility and Sterility 1983; 39:647-655.
25. World Health Organisation Task Force on Methods for the Determination of the Fertile Period. A prospective multicentre trial of the ovulation method of natural family planning. II. The effectiveness phase. Fertility and Sterility 1981; 36:591-598.
26. Flynn AM, Docker MF, McCarthy N, Royston JP. Detection of the fertile phase from changes in cervico-vaginal fluid volume. International Journal of Fertility 1988; 33(Suppl.):17-23.
27. Flynn AM, McCarthy AM, Docker M, Royston JP. The temporal relationship between vaginal fluid volumes obtained with the Rovumeter vaginal aspirator and the fertile phase of the cycle. Human Reproduction 1988; 3:201-205.
28. Royston JP. Statistical approaches to the prediction and detection of ovulation: detecting the signal among the noise. In: Ovulation: Methods for its Prediction and Detection. Editor: Jeffcoate SL. New York, NY: John Wiley & Sons Ltd, 1983; pp. 19-32.
29. Collins WP. Hormonal indices of ovulation and the fertile period. Advances in Contraception 1985; 1:279-294.
30. Gross BA. Natural family planning indicators of ovulation. Clinical Reproduction and Fertility 1987; 5:91-117.
31. Hilgers TW, Daly KD, Prebil AM, Hilgers SK. Natural family planning. III. Intermenstrual symptoms and estimated time of ovulation. Obstetrics and Gynecology 1981; 58:152-155.
32. Billings EL, Brown JB, Billings JJ, Burger HG. Symptoms and hormonal changes accompanying ovulation. Lancet 1972; 1:282-284.
33. Hilgers TW, Abraham GE, Cavanagh D. Natural family planning. I. The peak symptom and estimated time of ovulation. Obstetrics and Gynecology 1978; 52:575-582.
34. Fehring RJ. Accuracy of the peak day of cervical mucus as a biological marker of fertility. Contraception 2002; 66:231-235.
35. World Health Organisation Task Force on Methods for the Determination of the Fertile Period. The measurement of urinary steroid glucuronides as indices of the fertile period in women. Journal of Steroid Biochemistry 1982; 17:695-702.
36. World Health Organisation Task Force on Methods for the Determination of the Fertile Period. Temporal relationships between ovulation and defined changes in the concentrations of plasma estradiol-17β, luteinizing hormone, follicle-stimulating hormone and progesterone. I. Probit analysis. American Journal of Obstetrics and Gynecology 1980; 138:383-390.
37. World Health Organisation. A prospective multicentre trial of the ovulation method of natural family planning. III. Characteristics of the menstrual cycle and of the fertile phase. Fertility and Sterility 1983; 40:773-778.
38. Riad-Fahmy D, Read GF, Walker RF, Walker SM, Griffiths K. Determination of ovarian steroid hormone levels in saliva. An overview. Journal of Reproductive Medicine 1987; 32:254-272.
39. Kerin JF, Edmonds DK, Warnes GM, Cox LW, Seamark RF, Matthews CD, et al. Morphological and functional relations of Graafian follicle growth to ovulation in women using ultrasonic, laparascopic and biochemical measurements. British Journal of Obstetrics and Gynaecology 1981; 88:81-90.
40. Usala SJ, Schumacher GF. Volumetric self-sampling of cervicovaginal fluid: a new approach to ovulation timing. Fertility and Sterility 1983; 39:304-309.
41. Gnoth C, Frank-Herrmann P, Bremme M, Freundl G, Godehardt E. [How do self-observed cycle symptoms correlate with ovulation?] Zentralblat Gynakologie 1996; 118:650-654 (German).
42. Baird DD, McConnaughey DR, Weinberg CR, Musey PI, Collins DC, Kesner JS, et al. Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites. Epidemiology 1995; 6:547-550.
43. Lasley BL, Stabenfeldt GH, Overstreet JW, Hanson FW, Czekala N, Munro C. Urinary hormone levels at the time of ovulation and implantation. Fertility and Sterility 1985; 43:861-867.
44. Baird DD, Weinberg CR, Wilcox AJ, McConnaughey DR, Musey PI. Using the ratio of urinary oestrogen and progesterone metabolites to estimate day of ovulation. Statistics in Medicine 1991; 10:255-266.
45. Tavmergen E, Sendag F, Goker EN, Levi R. Value of serum CA-125 concentrations as predictors of pregnancy in assisted reproduction cycles. Human Reproduction 2001; 16:1129-1134.
46. Katano K, Matsumoto Y, Ogasawara M, Aoyama T, Ozaki Y, Kajiura S, et al. Low serum M-CSF levels are associated with unexplained recurrent abortion. American Journal of Reproductive Immunology 1997; 38:1-5.
47. Dubowy RL, Feinberg RF, Keefe DL, Doncel GF, Williams SC, McSweet JC, et al. Improved endometrial assessment using cyclin E and p27. Fertility and Sterility 2003; 80:146-156.
48. Tabibzadeh S, Mason JM, Shea W, Cai Y, Murray MJ, Lessey B. Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility. Journal of Clinical Endocrinology and Metabolism 2000; 85:2526-2536.
49. Damario MA, Lesnick TG, Lessey BA, Kowalik A, Mandelin E, Seppala M, et al. Endometrial markers of uterine receptivity utilizing the donor oocyte model. Human Reproduction 2001; 16:1893-1899.
50. BIOSERV Diagnostics GmbH 2006. Glycodelin (placenta protein 14, pp 14) ELISA from BIOSERV Diagnostics. http://www.bioserv-diagnostics.com/ risk_pregnancy_monitoring/glycodelin.htm (accessed 5 January 2006).
51. Stavreus-Evers A, Aghajanova L, Brismar H, Eriksson H, Landgren BM, Hovatta O. Co-existence of heparin-binding epidermal growth factor-like growth factor and pinopodes in human endometrium at the time of implantation. Molecular Human Reproduction 2002; 8:765-769.
52. Taylor HS, Arici A, Olive D, Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. Journal of Clinical Investigation 1998; 101:1379-1384.
53. Taylor HS, Igarashi P, Olive DL, Arici A. Sex steroids mediate HOXA11 expression in the human peri-implantation endometrium. Journal of Clinical Endocrinology and Metabolism 1999; 84:1129-1135.
54. Licht P, Russu V, Lehmeyer S, Moll J, Siebzehnrubl E, Wildt L. Intrauterine microdialysis reveals cycle-dependent regulation of endometrial insulin-like growth factor binding protein-1 secretion by human chorionic gonadotropin. Fertility and Sterility 2002; 78:252-258.
55. Meyer WR, Castelbaum AJ, Somkuti S, Sagoskin AW, Doyle M, Harris JE, et al. Hydrosalpinges adversely affect markers of endometrial receptivity. Human Reproduction 1997; 12:1393-1398.
56. Reddy KV, Meherji PK. Integrin cell adhesion molecules in endometrium of fertile and infertile women throughout menstrual cycle. Indian Journal of Experimental Biology 1999; 37:323-331.
57. Reddy VR, Gupta SM, Meherji PK. Expression of integrin receptors on peripheral lymphocytes: correlation with endometrial receptivity. American Journal of Reproductive Immunology 2001; 46:188-195.
58. Inagaki N, Stern C, McBain J, Lopata A, Kornman L, Wilkinson D. Analysis of intra-uterine cytokine concentration and matrix-metalloproteinase activity in women with recurrent failed embryo transfer. Human Reproduction 2003; 18:608-615.
59. Aghajanova L, Stavreus-Evers A, Nikas Y, Hovatta O, Landgren BM. Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium. Fertility and Sterility 2003; 79(Suppl. 1):808-814.
60. Kliman HJ, Feinberg RF, Schwartz LB, Feinman MA, Lavi E, Meaddough EL. A mucin-like glycoprotein identified by MAG (mouse ascites Golgi) antibodies. Menstrual cycledependent localization in human endometrium. American Journal of Pathology 1995; 146:166-181.
61. Meseguer M, Pellicer A, Simon C. MUC1 and endometrial receptivity. Molecular Human Reproduction 1998; 4:1089-1098.
62. Westergaard LG, Wiberg N, Andersen CY, Laursen SB, Kliem A, Westergaard JG, et al. Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles. Human Reproduction 1998; 13:2612-2619.
63. Morton H, Rolfe B, Clunie GJ. An early pregnancy factor detected in human serum by the rosette inhibition test. Lancet 1977; 1:394-397.
64. Fan XG, Zheng ZQ. A study of early pregnancy factor activity in preimplantation. American Journal of Reproductive Immunology 1997; 37:359-364.
65. Cavanagh AC, Morton H, Rolfe BE, Gidley-Baird AA. Ovum factor: a first signal of pregnancy? American Journal of Reproductive Immunology 1982; 2:97-101.
66. Cavanagh AC, Morton H. The purification of early-pregnancy factor to homogeneity from human platelets and identification as chaperonin 10. European Journal of Biochemistry 1994; 222:551-560.
67. Waddell RS. FertilityPlus: Home Pregnancy Test hCG Levels & FAQ. http://www.fertilityplus.org/faq/hpt.html (accessed 5 January 2006).
68. Horcajadas JA, Riesewijk A, Martín J, Cervero A, Mosselman S, Pellicer A, et al. Global gene expression profiling of human endometrial receptivity. Journal of Reproductive Immunology 2004; 63:41-49.
69. Cho SI, Goldman MB, Ryan LM, Chen C, Damokosh AI, Christiani DC, et al. Reliability of serial urine HCG as a biomarker to detect early pregnancy loss. Human Reproduction 2002; 17:1060-1066.
70. Lockwood GM, Muttukrishna S, Ledger WL. Inhibins and activins in human ovulation, conception and pregnancy. Human Reproduction Update 1998; 4:284-295.
71. Han VKM, Bassett N, Walton J, Challis JRG. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. Journal of Clinical Endocrinology and Metabolism 1996; 81:2680-2693.
72. Aronow BJ, Richardson BD, Handwerger S. Microarray analysis of trophoblast differentiation: gene expression reprogramming in key gene function categories. Physiological Genomics 2001; 6:105-116.
73. Simón C, Caballero-Campo P, Garcia-Velasco JA, Pellicer A. Potential implications of chemokines in reproductive function: an attractive idea. Journal of Reproductive Immunology 1998; 38:169-193.
74. Krussel J-S, Bielfeld P, Polan ML, Simón C. Regulation of embryonic implantation. European Journal of Obstetrics and Gynecology 2003; 110(Suppl. 1):S2-S9.
75. Simón C, Moreno C, Remohí J, Pellicer A. Molecular interactions between embryo and uterus in the adhesion phase of human implantation. Human Reproduction 1998; 13(Suppl. 3):219-236.
76. De los Santos MJ, Mercader A, Frances A, Portoles E, Remohí J, Pellicer A, et al. Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development. Biology of Reproduction 1996; 54:563-574.
77. Lim KJH, Odukoya OA, Li TC, Cooke ID. Cytokines and immuno-endocrine factors in recurrent miscarriage. Human Reproduction Update 1996; 2:469-481.
78. Bell SC, Patel SR, Jackson JA, Waites GT. Major secretory protein of human decidualized endometrium in pregnancy is an insulin-like growth factor-binding protein. Journal of Endocrinology 1988; 118:317-328.
79. Tseng L, Gao J, Mazella J, Zhu HH, Lane B. Differentiation-dependent and cell-specific regulation of the hIGFBP-1 gene in human endometrium. Annals of the New York Academy of Sciences 1997; 828:27-37.
80. Simón C, Dominguez F, Remohí J, Pellicer A. Embryo effects in human implantation: embryonic regulation of endometrial molecules in human implantation. Annals of the New York Academy of Sciences 2001; 943:1-16.
81. Meseguer M, Aplin JD, Caballero-Campo P, O'Connor JE, Martín JC, Remohí J, et al. Human endometrial mucin MUC1 is up-regulated by progesterone and down-regulated in vitro by the human blastocyst. Biology of Reproduction 2001; 64:590-601.
82. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. New England Journal of Medicine 2005; 353:2001-2011.
83. Birken S, Kovalevskaya G, O'Connor J. Immunochemical measurement of early pregnancy isoforms of HCG: potential applications to fertility research, prenatal diagnosis, and cancer. Archives of Medical Research 2001; 2032:635-643.
84. Braunstein GD. Endocrinology changes in pregnancy, Chapter 20. In: Williams Textbook of Endocrinology, 10th edn. Editors: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS. Philadelphia, PA: Saunders, 2003; pp. 795-810.
85. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proceedings of the National Academy of Sciences of the USA 1999; 96:3149-3153.
86. Conover CA, Faessen GF, Ilg KE, Chandrasekher YA, Christensen M, Overgaard MT, et al. Pregnancy-associated plasma protein-A is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum. Endocrinology 2001; 142:2155-2158.
87. Tong S, Marjono B, Brown DA, Mulvey S, Breit SN, Manuelpillai U, et al. Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage. Lancet 2004; 363:129-130.
88. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. New England Journal of Medicine 1995; 333:1517-1521.
89. Dunson DB, Weinberg CR. Modeling human fertility in the presence of measurement error. Biometrics 2000; 56:288-292.
90. Dunson DB, Weinberg CR, Baird DD, Kesner JS, Wilcox AJ. Assessing human fertility using several markers of ovulation. Statistics in Medicine 2001; 20:965-978.
91. Lasley BL, Mobed K, Gold EB. The use of urinary hormonal assessments in human studies. Annals of the New York Academy of Sciences 1994; 709:299-311.
92. Plasma Inhibin. http://europe.obgyn.net/nederland/mp/overgang/images/ overgang14x.gif (accessed 4 January 2006).
93. Sinosich MJ, Bonifacio MD, Saunders DM. Pregnancy-associated plasma protein-A: a marker of placental function? Annals of the New York Academy of Sciences 1988; 541:510-513.
94. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, et al. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proceedings of the National Academy of Sciences of the USA 2003; 100:13350-13355.
95. Miner D, Rajkovic A. Identification of expressed sequence tags preferentially expressed in human placentas by in silico subtraction. Prenatal Diagnosis 2003; 23:410-419.
96. Kao LC, Tulac S, Lobo S, Imani B, Yang JP, Germeyer A, et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002; 143:2119-2138.
97. Borthwick JM, Charnock-Jones DS, Tom BD, Hull ML, Teirney R, Phillips SC, et al. Determination of the transcript profile of human endometrium. Molecular Human Reproduction 2002; 9:19-33.
98. Carson DD, Lagow E, Thathiah A, Al-Shami R, Farach-Carson MC, Vernon M, et al. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Molecular Human Reproduction 2002; 8:871-879.
99. Riesewijk A, Martin J, van Os R, Horcajadas JA, Polman J, Pellicer A, et al. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Molecular Human Reproduction 2003; 9:253-264.